AALL1732
OPEN TO ACCRUAL
Phase 3 Inotuzumab Ozogamicin for Newly Dx HR B ALL plus MPAL and Disseminated B LLy
AALL2131
OPEN TO ACCRUAL
Pilot Study of Chemo and TKIs with Blinatumomab in New Dx Ph+ or Ph-like B-ALL
APEC14B1
OPEN TO ACCRUAL
Project: Every Child A Registry, Eligibility Screening, Biology and Outcome Study